InsidersTradesSigma
Track the MESOBLAST LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the oversight of ASX. Market capitalisation: €2.7bn. The latest transaction was filed on 15 June 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
MESOBLAST LIMITED is a biopharmaceutical company focused on developing cellular therapies. It is listed on the Australian Securities Exchange (XASX).